Prebiotic Activity of Tart Cherry and the Immunoregulation of Bone Homeostasis
酸樱桃的益生元活性和骨稳态的免疫调节
基本信息
- 批准号:10046896
- 负责人:
- 金额:$ 44.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptionAgeAge-Related Bone LossAnimal ModelAnimalsAnthocyaninsBacillusBone ResorptionButyratesC57BL/6 MouseCalciumCell Differentiation processCellsCherry - dietaryClinical ResearchDataDietDietary InterventionDietary SupplementationDiseaseFDA approvedFermentationFiberFoundationsFractureFrightFruitFutureGoalsGut associated lymphoid tissueHealthcare SystemsHomeostasisIL2RA geneImmunologicsInflammatoryInterferonsInterleukin-10IntestinesLactobacillus casei rhamnosusMediatingMusculoskeletal DiseasesNatural ProductsOligosaccharidesOsteogenesisOsteoporosisPatientsPeripheralPharmaceutical PreparationsPharmacologyPrevention strategyProbioticsProcessProductionPublic HealthRegimenReportingResearch DesignResearch PersonnelRoleSiteSourceSupplementationT-LymphocyteTestingTherapeuticTumor Necrosis Factor SuppressionUp-RegulationVolatile Fatty AcidsWNT Signaling PathwayWomanage relatedaging populationbonebone losschronic paincommensal microbescostdesigndisabilityexperiencefructooligosaccharidegut microbiotaimmunoregulationinsightinterestmenmicrobiotanovelnovel strategiesnovel therapeuticsosteoblast differentiationosteoclastogenesisosteoporosis with pathological fracturephenolic acidprebioticspreventprotective effectresponseside effectskeletaltherapeutic targettraining opportunitytreatment strategyundergraduate studentuptake
项目摘要
Project Summary/Abstract:
Worldwide, an estimated 1 in 3 women and 1 in 5 men over the age of 50 y experience an osteoporotic
fracture. In the U.S. alone, the impact on the healthcare system is $19 billion annually, but with our
aging population and poor compliance with existing pharmacological options these costs are expected
to escalate. Consequently, the search has continued for alternative strategies to prevent and treat
osteoporosis. Recent reports targeting the gut-bone axis have provided renewed interest in the role of
nutritional interventions. Compelling evidence has shown that probiotics increase short chain fatty
acids (SCFAs), which in turn promote the differentiation of T regulatory (TREG) cells that mediate
osteoprotective effects. The bone-protective benefits of classic prebiotics (i.e., fibers) have been
attributed to a SCFA-induced increase in intestinal calcium uptake; however, insights gained more
recently from studies of probiotics raise the question of whether prebiotics target gut commensal
microbiota and alter bone homeostasis by similar immunoregulatory mechanisms. The recent adoption
of a more comprehensive definition of prebiotics has revealed that natural products such as tart
cherries provide an excellent source of fructo-oligosaccharide, anthocyanin and phenolic acid, each
with notable prebiotic activity. Preliminary data from our lab will show that supplementing the diet
with tart cherry promotes bone accrual, protects against bone loss, increases SCFAs (e.g., butyrate), and
downregulates inflammatory processes in gut-associated lymphoid tissues. The goal of this project is to
determine the extent to which the prebiotic activity of tart cherry mediates it effects on bone via
butyrate-induced alterations in TREG cells. We hypothesize that the benefits of tart cherry
supplementation on bone are mediated, at least in part, by enhanced TREG differentiation resulting from
alterations in the gut microbiota and the consequent increase in butyrate production. The following
aims have been developed to test this hypothesis: Aim 1) To determine how dietary supplementation
with tart cherry alters bone homeostasis and the extent to which these effects are mediated by
alterations in TREG cells; and Aim 2) To investigate the role of butyrate derived from the gut microbiota
on this skeletal response. The proposed studies will advance our understanding of how the bioactive
components in tart cherry mediate their effects on the gut-bone axis in addition to providing an
excellent training opportunity for undergraduate researchers. Furthermore, these findings could
establish the foundation for future clinical studies designed to target the gut with prebiotics, which is in
line with our long-term goal of developing alternative therapeutic strategies for the prevention and
treatment of osteoporosis.
项目概要/摘要:
在世界范围内,估计有1/3的女性和1/5的男性在50岁以上的经验,
骨折仅在美国,每年对医疗保健系统的影响就达190亿美元,但随着我们的
人口老龄化和对现有药物选择的依从性差,这些成本是预期的
升级因此,继续寻找替代策略来预防和治疗
骨质疏松最近针对肠-骨轴的报道重新引起了人们对
营养干预。令人信服的证据表明,益生菌会增加短链脂肪
酸(SCFAs),这反过来又促进T调节(TREG)细胞的分化,
骨保护作用。传统益生元的骨骼保护益处(即,纤维)已
归因于SCFA诱导的肠道钙摄取增加;然而,
最近,益生菌的研究提出了益生元是否靶向肠道微生物的问题,
通过类似的免疫调节机制改变骨稳态。最近通过
对益生元更全面的定义表明,天然产品,如果馅饼,
樱桃是低聚果糖、花青素和酚酸的极好来源,
具有显著的益生元活性我们实验室的初步数据显示,
酸樱桃促进骨生成,防止骨丢失,增加SCFA(例如,丁酸盐),和
下调肠道相关淋巴组织中的炎症过程。该项目的目标是
确定酸樱桃的益生元活性在多大程度上介导了它对骨骼的影响,
丁酸盐诱导的Treg细胞的改变。我们假设酸樱桃的好处
补充剂对骨的作用至少部分是由增强的TREG分化介导的,
肠道微生物群的改变以及随之而来的丁酸盐产量的增加。以下
目的是为了验证这一假设:目的1)确定膳食补充剂如何
酸樱桃改变了骨内稳态,这些作用在多大程度上是由
目的2)研究来源于肠道微生物群的丁酸盐的作用
骨骼的反应。拟议的研究将促进我们对生物活性物质如何
酸樱桃中的成分除了提供一种
为本科研究人员提供了极好的培训机会。此外,这些发现可能
为未来旨在用益生元靶向肠道的临床研究奠定基础,
符合我们开发预防和治疗替代治疗策略的长期目标
骨质疏松症的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEPHEN L CLARKE其他文献
STEPHEN L CLARKE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEPHEN L CLARKE', 18)}}的其他基金
Prebiotic Activity of Tart Cherry and the Immunoregulation of Bone Homeostasis
酸樱桃的益生元活性和骨稳态的免疫调节
- 批准号:
10388465 - 财政年份:2020
- 资助金额:
$ 44.09万 - 项目类别:
Molecular Coordination of Iron Homeostasis by microRNAs
microRNA 对铁稳态的分子协调
- 批准号:
7939530 - 财政年份:2010
- 资助金额:
$ 44.09万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A randomized, double-blind, placebo-controlled, clinical trial of a probiotic/prebiotic supplement for the dietary management of age-related bone loss.
益生菌/益生元补充剂用于饮食管理与年龄相关的骨质流失的随机、双盲、安慰剂对照临床试验。
- 批准号:
10733549 - 财政年份:2023
- 资助金额:
$ 44.09万 - 项目类别:
Doctoral Dissertation Research: Exploring Localized Relationships Between Age-related Bone Loss and Cortical Expansion in Diaphyseal Bone
博士论文研究:探索年龄相关骨丢失与骨干皮质扩张之间的局部关系
- 批准号:
2141878 - 财政年份:2022
- 资助金额:
$ 44.09万 - 项目类别:
Standard Grant
Influence of aging on the preB cell product, λ5, and its contribution to age-related bone loss
衰老对前 B 细胞产物 α5 的影响及其对与年龄相关的骨质流失的贡献
- 批准号:
10589513 - 财政年份:2022
- 资助金额:
$ 44.09万 - 项目类别:
Regulation of age-related bone loss by PKIgamma
PKIgamma 调节与年龄相关的骨质流失
- 批准号:
10208697 - 财政年份:2020
- 资助金额:
$ 44.09万 - 项目类别:
Regulation of age-related bone loss by PKIgamma
PKIgamma 调节与年龄相关的骨质流失
- 批准号:
10399612 - 财政年份:2020
- 资助金额:
$ 44.09万 - 项目类别:
Regulation of age-related bone loss by PKIgamma
PKIgamma 调节与年龄相关的骨质流失
- 批准号:
10615740 - 财政年份:2020
- 资助金额:
$ 44.09万 - 项目类别:
Effect of tea flavonoids and low dose estrogen on bone metabolism in an animal model for age-related bone loss
茶黄酮和低剂量雌激素对年龄相关性骨质流失动物模型骨代谢的影响
- 批准号:
488140-2016 - 财政年份:2018
- 资助金额:
$ 44.09万 - 项目类别:
Postdoctoral Fellowships
Effect of tea flavonoids and low dose estrogen on bone metabolism in an animal model for age-related bone loss
茶黄酮和低剂量雌激素对年龄相关性骨质流失动物模型骨代谢的影响
- 批准号:
488140-2016 - 财政年份:2017
- 资助金额:
$ 44.09万 - 项目类别:
Postdoctoral Fellowships
Development of a Wearable Electrical Stimulation Device to Mitigate Age-Related Bone Loss
开发可穿戴电刺激装置以减轻与年龄相关的骨质流失
- 批准号:
515665-2017 - 财政年份:2017
- 资助金额:
$ 44.09万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's